PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells (Q60211787)
Jump to navigation
Jump to search
scientific article published on 01 July 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells |
scientific article published on 01 July 2018 |
Statements
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells (English)
Evgeny Kulesskiy
Jaya Sangodkar
Anna Aakula
Sudeh Izadmehr
Pekka Haapaniemi
Michael Ohlmeyer
Jukka Westermarck
eaaq1093
0 references